F10 Gene Factor X deficiency Genetic Test
Test Name: F10 Gene Factor X deficiency Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Hematology
Doctor: Hematologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for F10 Gene Factor X deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with F10 Gene Factor X deficiency NGS Genetic DNA Test gene F10.
Test Details: F10 gene factor X deficiency NGS genetic test is a type of genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the F10 gene for any mutations or abnormalities. Factor X deficiency is a rare inherited bleeding disorder that affects the blood’s ability to clot properly. The F10 gene provides instructions for making a protein called coagulation factor X, which plays a crucial role in the blood clotting process. The NGS genetic test involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, which allows for the rapid and accurate analysis of the entire F10 gene. The test can identify any mutations or variations in the gene that may be associated with factor X deficiency. By identifying specific mutations or variations in the F10 gene, the test can help diagnose factor X deficiency and determine the specific genetic cause of the disorder. This information can be useful in guiding treatment decisions, predicting the risk of complications, and providing genetic counseling to affected individuals and their families. It is important to note that the F10 gene factor X deficiency NGS genetic test is a specialized test and is typically ordered by healthcare professionals with expertise in genetic testing and bleeding disorders. The test results should be interpreted in the context of a comprehensive clinical evaluation and may require further confirmatory testing.
Test Name | F10 Gene Factor X deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hematology |
Doctor | Hematologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for F10 Gene Factor X deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with F10 Gene Factor X deficiency NGS Genetic DNA Test gene F10 |
Test Details |
F10 gene factor X deficiency NGS genetic test is a type of genetic test that uses Next-Generation Sequencing (NGS) technology to analyze the F10 gene for any mutations or abnormalities. Factor X deficiency is a rare inherited bleeding disorder that affects the blood’s ability to clot properly. The F10 gene provides instructions for making a protein called coagulation factor X, which plays a crucial role in the blood clotting process. The NGS genetic test involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, which allows for the rapid and accurate analysis of the entire F10 gene. The test can identify any mutations or variations in the gene that may be associated with factor X deficiency. By identifying specific mutations or variations in the F10 gene, the test can help diagnose factor X deficiency and determine the specific genetic cause of the disorder. This information can be useful in guiding treatment decisions, predicting the risk of complications, and providing genetic counseling to affected individuals and their families. It is important to note that the F10 gene factor X deficiency NGS genetic test is a specialized test and is typically ordered by healthcare professionals with expertise in genetic testing and bleeding disorders. The test results should be interpreted in the context of a comprehensive clinical evaluation and may require further confirmatory testing. |